XML 65 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8
Derivative Financial Instruments
12 Months Ended
Dec. 28, 2013
Derivative Financial Instruments  
Derivative Financial Instruments

5. Derivative Financial Instruments

        The Company is exposed to interest rate fluctuations in the normal course of its business, including through its Credit Facilities. The interest payments on the facility are calculated using a variable-rate of interest. The Company has entered into an interest rate swap agreement with an original notional value of $100 million (equal to the full amount borrowed under the Term Loan Facility) and, effectively, converted the LIBOR portion of the variable-rate interest payments to fixed-rate interest payments through July 2017 (the maturity date of the Term Loan Facility). The Company's interest rate swap agreement is designated and qualifies as a cash flow hedge.

        The Company's previous swap agreement with a notional value of $50.1 million was terminated in fiscal 2012 in connection with the Company's purchase of its corporate headquarters facilities. See Note 9, Acquisitions, for additional information.

        The Company estimates the fair values of derivatives based on quoted prices and market observable data of similar instruments. If the Term Loan Facility or the interest rate swap agreement is terminated prior to maturity, the fair value of the interest rate swap recorded in accumulated other comprehensive loss may be recognized in the Consolidated Statement of Income based on an assessment of the agreements at the time of termination. The termination of the Company's swap agreement with a notional value of $50.1 million resulted in its remaining fair value of $0.9 million that was previously recorded in accumulated other comprehensive loss to be reclassified into earnings during fiscal 2012. The Company did not discontinue any other cash flow hedges in the periods presented.

        The Company measures the effectiveness of its cash flow hedge by comparing the change in fair value of the hedged variable interest payments with the change in fair value of the interest rate swap. The Company recognizes ineffective portions of the hedge, as well as amounts not included in the assessment of effectiveness, in the Consolidated Statement of Income. As of December 28, 2013, no portion of the gains or losses from the Company's hedging instrument was excluded from the assessment of effectiveness. Hedge ineffectiveness was not material for any of the periods presented.

        The Company's derivative financial instrument consisted of the following (in thousands):

 
   
  Fair Value  
 
  Balance Sheet Location   December 28,
2013
  December 29,
2012
 

Interest rate swap

  Other assets, net   $ 513   $  

 

  Other non-current liabilities         658  

        The before-tax effect of derivative instruments in cash flow hedging relationships was as follows (in thousands):

 
  Gain (Loss) Recognized in
OCI on Derivatives
(Effective Portion)
during the Year Ended
  Location
of Loss
Reclassified
into Income
  Loss Reclassified
from Accumulated
OCI into Income
(Effective Portion)
during the Year Ended
 
 
  December 28,
2013
  December 29,
2012
  December 31,
2011
   
  December 28,
2013
  December 29,
2012
  December 31,
2011
 

Interest rate swaps

  $ 611   $ (956 ) $ (424 ) Rent expense   $   $ (2,197 ) $ (2,237 )

 

                    Interest expense     (560 )   (98 )    

        The Company expects to reclassify $0.5 million of its interest rate swap losses included in accumulated other comprehensive loss as of December 28, 2013 into earnings in the next 12 months, which would be offset by lower interest payments.